Recombinant Adeno-Associated Viral Vectors in the Nervous System
- 1 July 2005
- journal article
- review article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 16 (7) , 781-791
- https://doi.org/10.1089/hum.2005.16.781
Abstract
Recombinant adeno-associated virus 2 (rAAV2) has been extensively used as a gene delivery vector for the nervous system. It targets primarily neurons in the nervous system and results in sustained long-term expression of transgenes. New rAAV serotypes have been characterized and demonstrated to have improved transduction efficiencies in various regions of the brain and spinal cord. This review discusses some properties of rAAV that have been studied in the nervous system such as cell tropism, duration of transgene expression, and distribution of viral transduction, as well as immunity and regulation of transgene expression issues, all of which are important for optimization of the use of rAAV in the nervous system.Keywords
This publication has 131 references indexed in Scilit:
- Transduction Profiles of Recombinant Adeno-Associated Virus Vectors Derived from Serotypes 2 and 5 in the Nigrostriatal System of RatsJournal of Virology, 2004
- Sustained tetracycline‐regulated transgene expression in vivo in rat retinal ganglion cells using a single type 2 adeno‐associated viral vectorThe Journal of Gene Medicine, 2003
- Targeting functional subtypes of spinal motoneurons and skeletal muscle fibers in vivo by intramuscular injection of adenoviral and adeno-associated viral vectorsBrain Structure and Function, 2002
- Delayed delivery of AAV-GDNF prevents nigral neurodegeneration and promotes functional recovery in a rat model of Parkinson's diseaseGene Therapy, 2002
- Recombinant AAV vectors containing the foot and mouth disease virus 2A sequence confer efficient bicistronic gene expression in cultured cells and rat substantia nigra neuronsGene Therapy, 2001
- Adeno-associated virus vector-mediated bcl-2 gene transfer into post-ischemic gerbil brain in vivo: prospects for gene therapy of ischemia-induced neuronal deathGene Therapy, 2000
- Adeno-Associated Virus-Mediated Gene Transfer to the Brain: Duration and Modulation of ExpressionHuman Gene Therapy, 1999
- Selective and Rapid Uptake of Adeno-Associated Virus Type 2 in BrainHuman Gene Therapy, 1998
- Ecdysone-inducible gene expression in mammalian cells and transgenic mice.Proceedings of the National Academy of Sciences, 1996
- Efficient selection for high-expression transfectants with a novel eukaryotic vectorGene, 1991